TELO — Telomir Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Telomir Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0	0.001	0.001	1.27	7.29
Net Total Receivables	—	—	0.13	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0	0.049	0.435	1.32	7.34
Other Long Term Assets
Total Assets	0	0.049	4.77	1.32	7.34
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.138	0.986	1.34	0.681	1.43
Total Long Term Debt
Total Debt
Total Liabilities	0.138	0.986	1.34	0.681	1.43
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.138	-0.937	3.44	0.643	5.91
Total Liabilities & Shareholders' Equity	0	0.049	4.77	1.32	7.34
Total Common Shares Outstanding